The abstract is read at the publisher; the summary is JClub's.
KCa2.3 is identified as the only Ca2+-activated K+ channel compatible with executing pacemaker function in glioblastoma, and its inhibition reduces pacemaker Ca2+ activity.
- Why it matters: Glioblastoma pacemaker cells coordinate tumor network rhythm and resilience, yet only KCa3.1 was previously known to drive this behavior, leaving other regulators and targets unclear.
- What they did: Using molecular Ca2+ integrator–based transcriptional profiling of highly Ca2+-active glioblastoma cells, the authors tested candidate regulators with genetic, pharmacological, and computational approaches across preclinical models and human specimens.
- The result: KCa2.3 expression increased in pacemaker cells, and perturbing KCa2.3 genetically or pharmacologically disrupted pacemaker function and reduced network-wide Ca2+ activity; edelfosine inhibition also reduced tumor burden in human brain spheroids.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.